Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Spinler

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
The skinny on treatment of venous thromboembolism in obesityS A Spinler
Pharmacotherapy|March 20, 2001
Activated partial thromboplastin time evaluationS A Spinler
Pharmacotherapy|December 28, 1999
Clinical trials of low-molecular-weight heparins in cardiologyS A Spinler
The American Journal of Managed Care|October 4, 1997
Cardiovascular drug prescribing patterns: where is the evidence of improvement?S A Spinler
American Journal of Hospital Pharmacy|August 1, 1991
How to prepare and deliver pharmacy presentationsS A Spinler
Circulation|May 13, 1998
Unfractionated heparin dosing in the FRIC studyS A Spinler
The Annals of Pharmacotherapy|January 1, 1992
Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast mediaS A Spinler, S Goldfarb
The Annals of Pharmacotherapy|April 1, 1996
More on comparison of HMG-CoA reductase inhibitorsI Hsu, S A Spinler
The Annals of Pharmacotherapy|December 10, 1997
Prehospital-initiated thrombolysisS A Spinler, P A Mikhail
The Annals of Pharmacotherapy|June 1, 1992
Upright tilt-table testing and drug therapy for recurrent vasovagal syncopeC A Elder, S A Spinler
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
The skinny on treatment of venous thromboembolism in obesityS A Spinler
Pharmacotherapy|March 20, 2001
Activated partial thromboplastin time evaluationS A Spinler
Pharmacotherapy|December 28, 1999
Clinical trials of low-molecular-weight heparins in cardiologyS A Spinler
The American Journal of Managed Care|October 4, 1997
Cardiovascular drug prescribing patterns: where is the evidence of improvement?S A Spinler
American Journal of Hospital Pharmacy|August 1, 1991
How to prepare and deliver pharmacy presentationsS A Spinler
Circulation|May 13, 1998
Unfractionated heparin dosing in the FRIC studyS A Spinler
The Annals of Pharmacotherapy|January 1, 1992
Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast mediaS A Spinler, S Goldfarb
The Annals of Pharmacotherapy|April 1, 1996
More on comparison of HMG-CoA reductase inhibitorsI Hsu, S A Spinler
The Annals of Pharmacotherapy|December 10, 1997
Prehospital-initiated thrombolysisS A Spinler, P A Mikhail
The Annals of Pharmacotherapy|June 1, 1992
Upright tilt-table testing and drug therapy for recurrent vasovagal syncopeC A Elder, S A Spinler
Pageof 5